Masimo Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Masimo Corporation's estimated annual revenue is currently $1.2B per year.
- Masimo Corporation's estimated revenue per employee is $289,335
- Masimo Corporation's total funding is $5M.
- Masimo Corporation's current valuation is $12.9B. (January 2022)
Employee Data
- Masimo Corporation has 4182 Employees.
- Masimo Corporation grew their employee count by 3% last year.
Masimo Corporation's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, Chairman & CEO | Reveal Email/Phone |
2 | Regional VP, Account Executive | Reveal Email/Phone |
3 | Sr. VP OEM Business | Reveal Email/Phone |
4 | Regional VP Sales- Southeast | Reveal Email/Phone |
5 | Area VP | Reveal Email/Phone |
6 | Area VP | Reveal Email/Phone |
7 | Regional VP Sales | Reveal Email/Phone |
8 | Regional VP Sales, US Post-Acute Care | Reveal Email/Phone |
9 | Area VP | Reveal Email/Phone |
10 | Regional VP Sales | Reveal Email/Phone |
Masimo Corporation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Masimo Corporation?
Founded in 1989, Masimo Corporation, the innovator of motion and low perfusion tolerant pulse oximetry, is a privately held medical technology company that develops, licenses and markets advanced medical signal processing technologies and products for the non-invasive monitoring of patient vital signs. Masimo Signal Extraction Technology pulse oximetry, Masimo SET®, represents a fundamental departure from conventional pulse oximetry technologies. Over 60 independent published studies have demonstrated that Masimo SET substantially overcomes the limitations of conventional pulse oximeters in accurately measuring arterial blood oxygen saturation levels and pulse rates in the presence of patient movement and low perfusion. To date, Masimo has licensed its Signal Extraction pulse oximetry technology to over 35 international patient monitoring systems providers, which make up over 60% of the world's pulse oximeter shipments. We invite you to learn more about the products, people, and services that have brought us to where we are today.
keywords:N/A$5M
Total Funding
4182
Number of Employees
$1.2B
Revenue (est)
3%
Employee Growth %
$12.9B
Valuation
N/A
Accelerator
Masimo Corporation News
Masimo Corp. v. True Wearables, Inc., No. 2021-2146, 2022 U.S. App. LEXIS 1923, at *17 (Fed. Cir. Jan. 24, 2022). This seems counter intuitive...
Masimo Corporation (MASI) stock is down -43.59% over the last 12 months, and the average rating from Wall Street analysts is a Buy.
Masimo (Nasdaq: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $597.4M | 4283 | 4% | N/A |
#2 | $1366.2M | 4831 | N/A | N/A |
#3 | $5110M | 4902 | 8% | $50.8M |
#4 | $2423.8M | 5327 | 4% | N/A |
#5 | $1464.6M | 5599 | -23% | $323M |